Skip to main content
Premium Trial:

Request an Annual Quote

Genpathway

Premium
Genpathway last week launched its Methylated DNA IP-on-Chip assays using Affymetrix GeneChip Tiling Arrays.
 
The assays include the Methylated DNA IP-on-Chip/Tiling assay, a Genome-wide assay using whole-genome tiling arrays; the Methylated DNA IP-on-Chip/Promoter assay for detection of methylated DNA in promoter regions; and the Methylated DNA Query assay for gene-by-gene analysis based on quantitative PCR.
 
According to Genpathway, the methylation assays, as well as analysis and services, will target pharmaceutical, biotechnology, and academic researchers. The assays could be used in biomarker discovery, drug target identification and validation, compound screening, and patient diagnosis and screening, the company said.

The Scan

Interfering With Invasive Mussels

The Chicago Tribune reports that researchers are studying whether RNA interference- or CRISPR-based approaches can combat invasive freshwater mussels.

Participation Analysis

A new study finds that women tend to participate less at scientific meetings but that some changes can lead to increased involvement, the Guardian reports.

Right Whales' Decline

A research study plans to use genetic analysis to gain insight into population decline among North American right whales, according to CBC.

Science Papers Tie Rare Mutations to Short Stature, Immunodeficiency; Present Single-Cell Transcriptomics Map

In Science this week: pair of mutations in one gene uncovered in brothers with short stature and immunodeficiency, and more.